Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · IEX Real-Time Price · USD
0.596
-0.021 (-3.34%)
At close: Jul 19, 2024, 4:00 PM
0.587
-0.009 (-1.49%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Bionano Genomics Stock Forecast
BNGO's stock price has decreased by -90.35% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Bionano Genomics stock have an average target of 4.00, with a low estimate of 2.00 and a high estimate of 6.00. The average target predicts an increase of 571.59% from the current stock price of 0.60.
Analyst Consensus: Buy
* Price targets were last updated on May 16, 2024.
Analyst Ratings
The average analyst rating for BNGO stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 2 | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
BTIG | BTIG | Strong Buy Maintains $3 → $2 | Strong Buy | Maintains | $3 → $2 | +235.80% | May 16, 2024 |
Scotiabank | Scotiabank | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +907.39% | Mar 7, 2024 |
Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 13, 2023 |
BTIG | BTIG | Strong Buy Maintains $2 → $10 | Strong Buy | Maintains | $2 → $10 | +1,578.98% | Aug 10, 2023 |
BTIG | BTIG | Strong Buy Maintains $30 → $20 | Strong Buy | Maintains | $30 → $20 | +3,257.96% | May 18, 2023 |
Financial Forecast
Revenue This Year
38.85M
from 36.12M
Increased by 7.56%
Revenue Next Year
48.30M
from 38.85M
Increased by 24.33%
EPS This Year
-1.77
from -6.81
EPS Next Year
-1.15
from -1.77
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 41.0M | 52.5M | 78.0M | 106.7M | 145.7M |
Avg | 38.8M | 48.3M | 75.8M | 103.7M | 141.5M |
Low | 36.3M | 44.1M | 72.8M | 99.6M | 136.0M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 13.4% | 35.2% | 61.6% | 40.8% | 40.5% |
Avg | 7.6% | 24.3% | 56.9% | 36.8% | 36.5% |
Low | 0.4% | 13.5% | 50.8% | 31.4% | 31.2% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -1.68 | -0.97 | -0.36 |
Avg | -1.77 | -1.15 | -0.35 |
Low | -1.83 | -1.30 | -0.33 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.